Get started

Neomatrix Biotech (Italy)

ROR: 02yrmma41
OpenAlex ID: I4405262379
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models
2021 · Antonella Conforti, Emanuele Marra, et al. · Molecular Therapy · 58
Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
2022 · Erika Salvatori, Lucia Lione, et al. · npj Vaccines · 53
PDF
The Nuts and Bolts of SARS-CoV-2 Spike Receptor-Binding Domain Heterologous Expression
2021 · Mariano Maffei, Linda Celeste Montemiglio, et al. · Biomolecules · 28
PDF
Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition
2021 · Lucia Lione, Erika Salvatori, et al. · OncoImmunology · 26
PDF
Linear DNA amplicons as a novel cancer vaccine strategy
2022 · Antonella Conforti, Erika Salvatori, et al. · Journal of Experimental & Clinical Cancer Research · 18
PDF
A linear DNA encoding the SARS-CoV-2 receptor binding domain elicits potent immune response and neutralizing antibodies in domestic cats
2023 · Antonella Conforti, Elisa Sanchez, et al. · Molecular Therapy — Methods & Clinical Development · 12
Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms
2023 · Federico D’Alessio, Lucia Lione, et al. · Vaccines · 8
PDF
A linear SARS-CoV-2 DNA vaccine candidate reduces virus shedding in ferrets
2023 · Mathias Martins, Gabriela M. do Nascimento, et al. · Archives of Virology · 6
PDF
DNA-Vaccine-Induced Immune Response Correlates with Lower Viral SARS-CoV-2 Titers in a Ferret Model
2022 · Mirco Compagnone, Eleonora Pinto, et al. · Vaccines · 5
PDF
Co-Delivery of the Human NY-ESO-1 Tumor-Associated Antigen and Alpha-GalactosylCeramide by Filamentous Bacteriophages Strongly Enhances the Expansion of Tumor-Specific CD8+ T Cells
2023 · Roberta Manco, Luciana D’Apice, et al. · Viruses · 3
PDF
Synthetic DNA vaccine platform elicits potent immunity where electroporated naked-mRNA is non-immunogenic
2026 · Claudia Tonini, Andrea Bianchi, et al. · Journal for ImmunoTherapy of Cancer · 2
PDF
COVID- e Vax, an electroporated plasmid DNA vaccine candidate encoding the SARS-CoV-2 Receptor Binding Domain, elicits protective immune responses in animal models of COVID-19
2021 · Antonella Conforti, Emanuele Marra, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2
PDF
Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects
2024 · Valentina Laquintana, Carla Mottini, et al. · Frontiers in Immunology · 1
Intramuscular plasmid DNA electroporation sequesters neoantigen-specific CD8+ T cells in treated muscle and limits tumor infiltration
2026 · Andrea Bianchi, Mauro Esposito, et al. · Molecular Therapy Oncology
PDF
Lipid deprivation amplifies type I IFN responses in monocytes through prenylation: insights from familial combined hypolipidemia type 2
2025 · Alessandra Pinzon Grimaldos, Ilenia Pacella, et al. · Journal of Translational Medicine
Supplementary Table 1 supporting the manuscript "Intramuscular plasmid DNA electroporation restrains Neoantigen-Specific CD8⁺ T Cells within vaccination site"
2025 · Esposito, Mauro, Palombo, Fabio · Zenodo (CERN European Organization for Nuclear Research)
1204 Synthetic linear DNA and functionalized LNPs enable rapid manufacture and delivery of personalized mRNA immunotherapies
2025 · Emily R Young, Ilaria Esposito, et al. · Journal for ImmunoTherapy of Cancer
PDF
1194 Synthetic linear DNA vaccines as a rapid and potent platform for personalized cancer immunotherapy
2025 · Fabio Palombo, Andrea Bianchi, et al. · Journal for ImmunoTherapy of Cancer
PDF
P08.03 Neoantigen cancer vaccine auguments anti CTLA-4 efficacy
2021 · F Palombo, E Salvatori, et al. · Journal for ImmunoTherapy of Cancer
PDF
Works count: 20
Citation count: 615
Year
Topic
Type